Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies

Publicaciones

Seladelpar: New hope for patients with primary biliary cholangitis

Autores: Yulia A Nevzorova, Francisco Javier Cubero
Publicado en: Med/ Cell Press, Edición 5 (5), 2024, ISSN 2666-6359
Editor: Science Direct
DOI: 10.1016/j.medj.2024.03.019

Mitochondrial cholesterol: Metabolism and impact on redox biology and disease

Autores: Leire Goicoechea,a,b,c Laura Conde de la Rosa,a,b,c Sandra Torres,a,b,c Carmen García-Ruiz,a,b,c,d,∗∗ and José C. Fernández-Checaa,b,c,d,∗
Publicado en: Redox Biology, 2023, ISSN 2213-2317
Editor: Elsevier
DOI: 10.1016/j.redox.2023.102643

Dietary and genetic disruption of hepatic methionine metabolism induce acid sphingomyelinase to promote steatohepatitis

Autores: Cristina Alarcón-Vila 1, Naroa Insausti-Urkia 1, Sandra Torres 1, Paula Segalés-Rovira 1, Laura Conde de la Rosa 1, Susana Nuñez 1, Raquel Fucho 1, Jose C Fernández-Checa 2, Carmen García-Ruiz 3
Publicado en: Redox Biology, 2023, ISSN 2213-2317
Editor: Elsevier BV
DOI: 10.1016/j.redox.2022.102596

aProceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)

Autores: Alvarado Tapias E, Maya Miles D, Albillos A, Aller R, Ampuero J, Andrade R, Arechederra M, ASpicueta P, Banales, JM, Blas García A, Capparros E, Cardoso Delgado T, Carrillo Vico A, Claria J, Cubero FJ. Díaz Ruíz A, Fernández-Barrena MG, ..., Gahete DM
Publicado en: Gastroenterol Hepatol, 2024, ISSN 2444-3824
Editor: Elsevier
DOI: 10.1016/j.gastrohep.2024.502207

Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)

Autores: Raquel Benedé, Francisco Javier Cubero, Yulia A. Nevzorova
Publicado en: Gut microbes, Edición 1, 2331460, 2024, ISSN 1949-0984
Editor: Taylor & Francis
DOI: 10.1080/19490976.2024.2331460

Prior drug allergies are associated with worse outcome in patients with idiosyncratic drug-induced liver injury: A machine learning approach for risk stratification

Autores: H. Niu, P. Solis-Muñoz, M. García-Cortés, J. Sanabria-Cabrera, M. Robles-Diaz, R. Romero-Flores, E. Bonilla-Toyos, A. Ortega-Alonso, J. M. Pinazo-Bandera, M. R. Cabello, F. Bessone, N. Hernandez, M. I. Lucena, R. J Andrade, I. Medina-Caliz, I. Álvarez-Álv
Publicado en: Pharmacological Research, Edición 199, 2024, ISSN 1043-6618
Editor: Academic Press
DOI: 10.1016/j.phrs.2023.107030

Advancing with cancer immunotherapeutics: CD29+ regulatory T cell antagonism

Autores: Francisco Javier Cubero; Pablo Sarobe; Gisa Tiegs
Publicado en: Gut, Edición 73, 2023, ISSN 0017-5749
Editor: BMJ Journals
DOI: 10.1136/gutjnl-2023-331048

JNKs protect from cholestatic liver disease progression by modulating Apelin signalling

Autores: Mohamed, Mohamed Ramadan; Haybaeck, Johannes; Wu, Hanghang; Su, Huan; Bartneck, Matthias; Lin, Cheng; Boekschoten, Mark V.; Boor, Peter; Goeppert, Benjamin; Rupp, Christian; Strnad, Pavel; Davis, Roger J.; Cubero, Francisco Javier; Trautwein, Christian
Publicado en: Crossref, 2023, ISSN 2589-5559
Editor: Elsevier
DOI: 10.1016/j.jhepr.2023.100854

Inhibition of ALK3-mediated signalling pathway protects against acetaminophen-induced liver injury

Autores: Patricia Marañón 1, Esther Rey 2, Stephania C Isaza 2, Hanghang Wu 3, Patricia Rada 4, Carmen Choya-Foces 2, Antonio Martínez-Ruiz 5, María Ángeles Martín 6, Sonia Ramos 6, Carmelo García-Monzón 2, Francisco Javier Cubero 7, Ángela M Valverde 4, Águeda Go
Publicado en: Redox Biology, 2024, ISSN 2213-2317
Editor: Elsevier
DOI: 10.1016/j.redox.2024.103088

Buscando datos de OpenAIRE...

Publicaciones

Compartir esta página

Descargar